Loading company…
Tianjin Kedao Boji Biotechnology researches and develops cell therapy technologies.
Founded in 2024 and based in Tianjin, China, Tianjin Kedao Boji Biotechnology conducts research and development in cell therapy. Its work includes cell culture systems, gene editing, immune cell therapies and solutions for clinical translation. The company received angel funding in July 2025 to expand research, improve manufacturing and advance clinical trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Tianjin Kedao Boji Biotechnology Co., Ltd.? This is my company